I-NEW YORK, ngoJuni 23, 2022 (i-GLOBE NEWSWIRE) - i-Reportlinker.com ibhengeza ukukhutshwa kwengxelo "I-Global Intravenous Therapy kunye ne-Intravenous Access Market Ubungakanani, iSabelo kunye neNgxelo yoHlalutyo lweNdlela yoShishino, iNjongo kunye noQoqosho nguMsebenzisi wokugqibela, isicelo, uhlobo, iNgingqi, 2022-2028″ https://www.reportlinker.com/p06283441/?utm_source=GNW Eyona ndlela ikhawulezayo yokufaka ulwelo kwiindawo ezahlukeneyo zomzimba ngonyango lwe-IV.Uhlaselo lwentliziyo, ukubetha, kunye netyhefu zonke ziphathwa ngeli chiza.Kule meko, isigulane kufuneka siphathwe ngechiza ngokukhawuleza, ngaloo ndlela sinikeze ichiza unyango lwe-immune, antibiotics, i-antifungars, i-antifungars i-Chemolin. unyango, kunye namachiza oxinzelelo lwegazi banikwa emithanjeni.Unyango lwe-Intravenous (IV) yindlela yokuhambisa amayeza kunye nolwelo emzimbeni ngokusebenzisa i-vein.Amayeza aqulethe iivithamini kunye neeminerali anikezelwa nge-intravenous drip okanye i-intravenous injection, evumela unyango ukuba luhambe ngokukhawuleza kwi-bloodstream.Ngokutsho koMda, i-IV yolawulo luxa isigulane sinokuthi sisebenzise i-tube ye-tube ngokuthe ngqo kwi-tube. iyeza okanye ukusilela kwesondlo.Unyango lwe-IV yindlela eqhelekileyo yokubonelela ngamanzi, iziyobisi, i-chemotherapy, kunye nokumpontshelwa igazi kwizigulane eziphelelwe ngamanzi.Ngexesha lolawulo lwe-IV, izixhobo ezahlukeneyo ze-IV ezifana ne-IV catheters, iipompo zokufakela, izixhobo ze-immobilization, kunye neekiti zokulawula zisetyenziswa.Ulawulo lonyango lwe-IV lukhawuleza, lulula ukulandela, kwaye alunayo impendulo ye-immune ye-immune kunye nemiphumo ye-immune ye-gastrointestinal. impompo yokufakela elawula ubungakanani beekhemikhali eziza kunikezelwa kumzimba kwaye zinokujongwa ngokulula.Imarike yonyango lwe-intravenous yehlabathi kunye nezixhobo zofikelelo ngomthambo kulindeleke ukuba zonyuke kwixesha loqikelelo.Ukuxhaphaka kwesifo seswekile, ukwanda kweengozi zendlela, kunye nokwanda kweenkqubo zotyando kulindeleke ukuba ziqhubele phambili ishishini. Ukuhanjiswa Iyeza nge-11 kaNovemba ka-2021 ngenxa yokuba Ukwazi ukumodareyitha amagumbi amaninzi omzimba ngaxeshanye. Ke ngoko, ngokunyuka kwenani lezigulana ezine-COVID-19 ezinxulumene ne-ARDS, imfuno yonyango lwe-IV kunye neemveliso zokufikelela kwi-intravenous ziyanda. Izifo ezinjengomhlaza, ukungaphumeleli kwezintso kunye nesifo senhliziyo, kunye neendlela zokuphila ezahlukeneyo ezifana noxinzelelo lwegazi oluphezulu, isifo sikashukela, ukutyeba kunye nokudandatheka, kufuna ukhathalelo olunzulu ngexesha lokuhlala esibhedlele. Kule minyaka imbalwa izayo, ukwanda komthwalo wezifo ezingapheliyo ezifana nesifo senhliziyo, umhlaza, isifo seswekile, kunye nokuguga, kuya kwandisa imfuno yonyango lwe-intravenous kunye nezixhobo zokhuseleko lwe-Technological Advances. Iimpompo zokufakela ingcebiso ziphakathi kwezibonelelo zobuchwepheshe ezinegalelo ekukhuseleni, umgangatho ophezulu wonyango lwe-intravenous (IVT) practice.Njengoko iteknoloji yezempilo iyinkqubo enzima, kunye nokucamngca kunye nengxoxo yemihla ngemihla ngabasebenzi bezempilo ababandakanyekayo kukhathalelo lwesigulane kwiyunithi yokunyamekela kakhulu, intsimi yokhathalelo iye yatshintsha kakhulu ngenxa yokubandakanywa kobuchwepheshe obutsha, kunye nezixhobo zokukhusela ezikumgangatho ophezulu zokufumana uncedo oluphezulu lwempompo yonyango kwimpompo yonyango ephezulu. (IVT) ukuziqhelanisa.Izithintelo zeMakethi Ukuveliswa kwempompo kufuna imimiselo engqongqo kunye neenkxalabo malunga neengxaki Inkqubo yokukhutshwa kwelayisenisi yeeprojekthi ezintsha iqhutywa malunga nokuveliswa kwempompo kunye nokudibanisa.Ukongezelela, ukunyuka kwemveliso ekhumbulayo ngenxa yeziphene zokuvelisa kuya kuthothisa ukwamkelwa kwezi zonyango.Ngokomzekelo, iFresenius Kabi ye-Fresenius Kabi yakhumbula i-Agasgamma MC I-Pump ye-Volgiliat kunye ne-Agastrum ye-Pump Deramp ye-Agas. Ngo-2019 ngenxa yemicimbi yesilumkiso sokufakelwa, ukubeka phambili okuphantsi Gcina iVein Open (KVO) kunye nezinye iibugs zesoftware.Umqobo omkhulu ekukhuleni koshishino ziingxaki ezinxulumene nokusetyenziswa kweendlela ze-IV kunye neemveliso zokufakelwa kwe-IV. Imbono yoMsebenzisi wokugqibela Ngokusekwe kumsebenzisi wokugqibela, imakethi yahlulwe kwizibhedlele, amaziko otyando lwe-ambulatory, kunye nesabelo esikhulu sonyango kwisibhedlele. kunye nokufikelela kwimarike ye-venous ngo-2021. Oku kungenxa yokunyuka kwenani lotyando olwenziweyo xa kuthelekiswa namaziko otyando lwe-ambulatory kunye neekliniki.Ukongezelela, ukukhula kwecandelo kwakubangelwa ukwanda kokusetyenziswa kwonyango lwe-intravenous kwizibhedlele, ezibandakanya unyango lwe-antibiotic emithanjeni, iziyobisi zezigulane ezinesifo sokukrala, iziyobisi ezingenakuthathwa, isampula yegazi, i-heacan therapy, i-heacan therapy, i-heacan therapy, i-heacan therapy, i-heacan therapy, i-heacan therapy, i-heacan therapy, i-heacan therapy, i-heacan therapy, i-heacan therapy, i-health, i-anti-thrombosis, i-heacan , i-heacan therapy, i-repeaventional, i-heacan therapy, i-heacan , i-repeaventional , i-repeacan, i-heacan, i-repea kunye notofelo-gazi .Imarike yonyango lwe-IV kunye nezixhobo zokufikelela kwi-venous ziyakhula ngenxa yenkqubela phambili yetekhnoloji kunye notyalo-mali esibhedlele.I-Application Outlook Ngokusekelwe kwisicelo, imarike yahlulahlulwe kulawulo lweziyobisi, iimveliso ezisekelwe kwigazi, izisombululo zesondlo kunye ne-buffer, kunye nemikhumbi yokwandisa.Ngo-2021, i-Volume Expander segment iya kufumana isabelo esibalulekileyo sonyango kunye nengeniso I-market.I-intravenous fluids ingaba luncedo kwinani elincinci leembaleki ezinolwelo; nangona kunjalo, oku kufuneka kugcinwe kubadlali bezinga eliphezulu kunye nembali yeempawu ezinamandla phantsi kokubekwa kweliso okulungileyo.Abanye abagijimi banokuzuza ngokusebenzisa i-expander.I-Intravenous fluids kunye ne-plasma binders azivumelekanga kukhuphiswano olulawulwa yi-WADA. ngokohlobo, imakethi yahlulwe ngokweecatheter zemithambo, iimpompo zokufakelwa, iinaliti ze-hypodermic, izibuko ezifakelwayo, kunye nabanye. Ngo-2021, icandelo le-catheter ye-intravenous liya kubamba esona sabelo sikhulu sengeniso kunyango lwe-intravenous (IV) kunye nokufikelela kwimarike ye-venous. ukuya kwiindawo ezahlukahlukeneyo zomzimba.I-Catheter ye-Intravenous iityhubhu ezincinci ezifakwe kwi-catheter yomzimba okanye i-lumen.I-catheter ye-intravenous yi-catheter ye-intravenous esetyenziselwa ukuhambisa iziyobisi, ulwelo, okanye ezinye iindlela zonyango ngokuthe ngqo kwi-bloodstream.Izininzi zihlala zifakwe kwi-vein engalweni, nangona zinokuthi zifakwe entanyeni, esifubeni, okanye kwiifom ze-agronous, ngokuxhomekeke kwiifom ze-agroin. Imbonakalo yeNgingqi Ngokusekwe kummandla, imakethi yahlulwe kuMntla Melika, iYurophu, iAsia Pacific kunye neLatin America, uMbindi Mpuma kunye neAfrika.Ngo-2021, uMntla Melika ngowona mmandla ukhokelayo kunyango lwe-intravenous (IV) kunye nokufikelela kwimakethi ngokubamba esona sabelo siphezulu sengeniso. ekuphuhliseni amaziko onyango angcono kunye nemisebenzi ye-R & D.Ingxelo yophando lwemarike ibandakanya uhlalutyo lwabachaphazelekayo abaphambili kwimarike.Iinkampani ezinkulu ezichazwe kwingxelo ziquka i-B. Braun Melsungen AG, i-Medtronic PLC, i-Terumo Corporation, i-Fresenius SE & Co. KGaA, i-Cardinal Health, Inc., i-Pfizer, Inc., i-Teleflex, i-Inc., i-Baxter SmithyD GroupsD Inc. Ubuchule kwi-Intravenous (IV) Therapy kunye ne-Intravenous Access Market ngo-Matshi 2022: UFresenius Kabi utyikitye isivumelwano sokufumana iFresenius Kabi, inkampani yezempilo yehlabathi. U-Baxter wenza ubambiswano kunye nomboneleli weteknoloji yezonyango wase-US u-Hillrom. Ngale ntsebenziswano, iinkampani zimbini zijolise ekuhlanganiseni amashishini amabini amakhulu eteknoloji yezonyango ukufikelela kwimbono ekwabelwana ngayo yokuguqula ukhathalelo lwezempilo lwehlabathi kunye nokuphucula ukhathalelo lwezigulane.May 2021: Smiths Medical iifom zentsebenziswano kunye nenkampani yobugcisa bezonyango Ivenix.Ngale ntsebenziswano, iinkampani zimbini zijolise ekunikezeni uluhlu olubanzi lwe-infusional infusions infusions infusions infusions-long-term partnership. yenzelwe ukuguqula ulawulo lokuxuba kunye nokuphucula impilo yesigulane, ngelixa ihlangabezana neemfuno zababoneleli bezempilo. Ngo-Aprili 2021: I-B. Braun Medical yasungula inkqubo entsha, i-Peripheral Advantage, ukuphucula amava ezigulane kunye nonyango lwe-peripheral intravenous. Ngo-2019: U-Baxter ufumana imvume ye-US Food and Drug Administration (i-FDA) ye-Myxredlin. Imvume ivumela i-insulin ekhawulezayo yokufakela i-intravenous kwizibhedlele kunye nezinye iisetingi zokhathalelo olunzima kwaye unobomi obuninzi beshelufu yeentsuku ezingama-30 okanye iinyanga ezingama-24 kwiqondo lobushushu begumbi ukuba ifakwe efrijini kwipakethe yokuqala ukuqinisekisa ukukhuselwa nguMsebenzisi weeNgxelo ze-Ambulali • Iingxelo zeSibhedlele se-Ambulary • Iingxelo zeSibhedlele soMsebenzi Ulawulo lwamayeza • Iimveliso zeGazi • Izisombululo zeZondlo kunye neBuffer • Izitya zoDiffusion ngokoHlobo • IiCatheter ezifakwa kwiMithano • IiPumpu zeInfusion • Iinaliti zeHypodermic • IiNaliti ezifakelwayo • Ezinye ngeJografi • kuMntla Melika o USo Canadao Mexico Kuphumlo loMntla Melika • IYurophu eJamani o UKo France IRashiya ISpain I-Itali o Inxalenye yeYurophu Yase-Asia • I-Asia Pacific China o I-Indiast Korea yase-Asia i-Asia PacificA I-Asia yase-Asia yase-Asia Pacific I-Nigeria LAMEA Rest Company Profile• B. Braun Melsungen AG • Medtronic PLC• Terumo Corporation• Fresenius SE & Co. KGaA• Cardinal Health, Inc.• Pfizer, Inc.• Teleflex, Inc.• Baxter International, Inc.• Smiths Group PLC• AngioDynamics, Inc. Uniquetive Exscriptions & Co. Imodeli Iyafumaneka • Ixabiso Elilungileyo Liqinisekisiweyo • Uphando lwasemva kwentengiso oluqinisekisiweyo luxhaswa yi-10% Customization Funda ingxelo epheleleyo simahla: https://www .reportlinker.com/p06283441/?utm_source=GNWAbout ReportlinkerReportLinker libhaso eliphumeleleyo lophando lwemakethi. I-Reportlinker unokufumana isisombululo sophando lwemarike yamva nje. indawo enye ___________________________________
Ixesha lokuposa: Jun-28-2022
